Drug Shortage Report for NARDIL
Report ID | 104431 |
Drug Identification Number | 00476552 |
Brand name | NARDIL |
Common or Proper name | NARDIL |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PHENELZINE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 TAB |
ATC code | N06AF |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-01-21 |
Actual start date | 2020-01-21 |
Estimated end date | 2020-08-12 |
Actual end date | 2020-08-12 |
Shortage status | Resolved |
Updated date | 2020-08-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-01-27 | French | Compare |
v2 | 2020-01-27 | English | Compare |
v1 | 2020-01-27 | English | Compare |